UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries

Clinical infectious diseases, 2009-10, Vol.49 (7), p.997-1005

2009

Volltextzugriff (PDF)

De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene

Brain (London, England : 1878), 2018-07, Vol.141 (7), p.1998-2013

2018

Volltextzugriff (PDF)

MLST reveals potentially high-risk international clones of Enterobacter cloacae

Journal of antimicrobial chemotherapy, 2015-01, Vol.70 (1), p.48-56

2015

Volltextzugriff (PDF)

Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy

Journal of Crohn's and colitis, 2020-11, Vol.14 (11), p.1524-1534

2020

Volltextzugriff (PDF)

P857 Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1587-i1587

2024

Volltextzugriff (PDF)

P927 Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID Study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1686-i1686

2024

Volltextzugriff (PDF)

P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1290-i1290

2024

Volltextzugriff (PDF)

P1071 Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1925-i1925

2024

Volltextzugriff (PDF)

P386 Persistence of bowel urgency despite clinical remission after induction therapy is associated with unfavorable long-term outcomes in patients with ulcerative colitis: results from the multicenter UC-RGENCY study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i812-i812

2024

Volltextzugriff (PDF)

Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn’s Disease

Journal of Crohn's and colitis, 2015-12, Vol.9 (12), p.1113-1119

2015

Volltextzugriff (PDF)

P322 Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter Study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i707-i707

2024

Volltextzugriff (PDF)

Monocyte-derived Macrophages from Crohn’s Disease Patients Are Impaired in the Ability to Control Intracellular Adherent-Invasive Escherichia coli and Exhibit Disordered Cytokine Secretion Profile

Journal of Crohn's and colitis, 2015-05, Vol.9 (5), p.410-420

2015

Volltextzugriff (PDF)

Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11

Journal of antimicrobial chemotherapy, 2015-07, Vol.70 (7), p.1981-1988

2015

Volltextzugriff (PDF)

P–324 Pregnancy outcome after IVF for endometriosis or male infertility: What differs?

Human reproduction (Oxford), 2021-08, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

Defining and Assessing the Reproducibility of Crohn’s Disease Endoscopic Lesions: A Delphi-like Method from the GETAID

Journal of Crohn's and colitis, 2021-06, Vol.15 (6), p.1000-1008

2021

Volltextzugriff (PDF)

P348 Top down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i361-i361

2022

Volltextzugriff (PDF)

DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i120-i120

2022

Volltextzugriff (PDF)

P400 Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i393-i394

2022

Volltextzugriff (PDF)

Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins

Journal of antimicrobial chemotherapy, 2015-12, Vol.70 (12), p.3230-3237

2015

Volltextzugriff (PDF)

Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study

Journal of Crohn's and colitis, 2022, Vol.16 (1), p.I393-I394

2022

Volltextzugriff (PDF)

DOP65 Infliximab plus azathioprine and quick steroids discontinuation versus azathioprine plus steroids in patients with acute severe Ulcerative Colitis responding to intravenous steroids: a parallel, open-label randomized controlled trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i191-i191

2024

Volltextzugriff (PDF)

Conditional switching of KIF2A mutation provides new insights into cortical malformation pathogeny

Human molecular genetics, 2020-03, Vol.29 (5), p.766-784

2020

Volltextzugriff (PDF)

P579 Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study

Journal of Crohn's and colitis, 2023-02, Vol.17 (Supplement_1), p.i707-i707

2023

Volltextzugriff (PDF)

Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia

Brain (London, England : 1878), 2011-01, Vol.134 (Pt 1), p.143-156

2011

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(101)

Sprache

Englisch
(101)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adequacy of Antimicrobial Treatment and Outcome of Staphylococcus aureus Bacteremia in 9 Western European Countries

De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene

MLST reveals potentially high-risk international clones of Enterobacter cloacae

Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn’s Disease Treated with Anti-Tumour Necrosis Factor Therapy

P857 Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study

P927 Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID Study

P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial

P1071 Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID

P386 Persistence of bowel urgency despite clinical remission after induction therapy is associated with unfavorable long-term outcomes in patients with ulcerative colitis: results from the multicenter UC-RGENCY study

Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn’s Disease

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

P322 Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter Study

Monocyte-derived Macrophages from Crohn’s Disease Patients Are Impaired in the Ability to Control Intracellular Adherent-Invasive Escherichia coli and Exhibit Disordered Cytokine Secretion Profile

Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11

P–324 Pregnancy outcome after IVF for endometriosis or male infertility: What differs?

Defining and Assessing the Reproducibility of Crohn’s Disease Endoscopic Lesions: A Delphi-like Method from the GETAID

P348 Top down versus step-up strategies to prevent postoperative recurrence in Crohn’s disease

DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

P400 Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study

Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins

Evolution of clinical and pharmacological parameters after switching from intra-venous to subcutaneous infliximab in patients with inflammatory bowel disease: the REMSWITCH study

DOP65 Infliximab plus azathioprine and quick steroids discontinuation versus azathioprine plus steroids in patients with acute severe Ulcerative Colitis responding to intravenous steroids: a parallel, open-label randomized controlled trial

Conditional switching of KIF2A mutation provides new insights into cortical malformation pathogeny

P579 Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study

Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia

Aktive Filter

Suchergebnisse filtern